Melissa A. Starovasnik, Director at Twist Bioscience Corp (TWST), sold 500 shares at $61.04 ($31K) on 2026-05-26, disclosed to the SEC on 2026-05-28.
Scheduled sale ($31k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| TWST | SELL | 2026-04-03 | $51K | — | Filing → |
| TWST | SELL | 2023-02-13 | $46K | — | Filing → |